Overview
All inclusive formulary for ocular prescription medications
Including new agents in retinal disease
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (12 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products – macugen, lucentis, etc. – and intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets have grown tremendously in the last 2-3 years (endura, restasis, xibrom, etc).
Authors and Affiliations
Bibliographic Information
Book Title: Ophthalmologic Drug Guide
Authors: Douglas J. Rhee, Kathryn A. Colby, Christopher J. Rapuano, Lucia Sobrin
DOI: https://doi.org/10.1007/978-0-387-49964-2
Publisher: Springer New York, NY
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag New York 2007
eBook ISBN: 978-0-387-49964-2Published: 06 March 2007
Edition Number: 1
Number of Pages: XII, 142
Topics: Ophthalmology